Google Alert - in

	in As-it-happens update ⋅ 10 March 2025
	WEB
	WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin ... Ionis Pharmaceuticals Second major approval for WAINZUA, which is marketed in the U.S. as WAINUA™ –. – EU approval based on NEURO-TTRansform Phase 3 results showing ... Flag as irrelevant

You have received this email because you have subscribed to Google Alerts. Unsubscribe

Receive this alert as RSS feed

Send Feedback

ShareThis